First Header Logo Second Header Logo

Jill Ohar

Concepts (210)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pulmonary Disease, Chronic Obstructive
31
2019
120
10.160
Why?
Bronchodilator Agents
12
2019
82
3.880
Why?
Glycopyrrolate
3
2019
3
2.080
Why?
Muscarinic Antagonists
3
2019
15
1.930
Why?
Lung
7
2019
233
1.820
Why?
Smoking
13
2016
427
1.650
Why?
Patient Readmission
3
2017
105
1.630
Why?
Asbestos
5
2015
8
1.550
Why?
Forced Expiratory Volume
11
2019
112
1.220
Why?
Mesothelioma
3
2015
38
1.130
Why?
Asthma
6
2018
397
1.120
Why?
Nebulizers and Vaporizers
4
2018
13
1.110
Why?
Disease Progression
4
2017
572
1.090
Why?
Administration, Inhalation
10
2019
92
1.020
Why?
Ethanolamines
2
2015
16
0.960
Why?
Adrenal Cortex Hormones
2
2018
148
0.830
Why?
Spirometry
4
2019
32
0.770
Why?
Humans
41
2019
29013
0.760
Why?
Adrenergic beta-Agonists
2
2018
50
0.750
Why?
Glucocorticoids
2
2012
149
0.720
Why?
Respiratory System Agents
1
2019
1
0.710
Why?
Middle Aged
25
2019
10805
0.710
Why?
Quinolones
1
2019
6
0.710
Why?
Ubiquitin Thiolesterase
2
2015
9
0.700
Why?
Indans
1
2019
25
0.700
Why?
Tumor Suppressor Proteins
2
2015
72
0.660
Why?
Severity of Illness Index
7
2019
863
0.650
Why?
Aged
21
2019
9462
0.640
Why?
Vital Capacity
5
2019
44
0.640
Why?
Lung Neoplasms
2
2015
384
0.630
Why?
Medicare
2
2017
185
0.620
Why?
Male
28
2019
17768
0.620
Why?
Female
27
2019
18114
0.620
Why?
Polymorphism, Single Nucleotide
4
2010
1079
0.600
Why?
Germ-Line Mutation
2
2015
17
0.590
Why?
Drug Combinations
4
2019
85
0.570
Why?
Treatment Outcome
8
2019
3099
0.550
Why?
Coronary Disease
2
2016
197
0.540
Why?
Benzyl Alcohols
1
2015
1
0.530
Why?
Chlorobenzenes
1
2015
2
0.530
Why?
Quinuclidines
1
2015
3
0.530
Why?
Androstadienes
1
2014
17
0.510
Why?
Patient Selection
1
2016
257
0.500
Why?
Albuterol
1
2014
40
0.500
Why?
Mutation, Missense
2
2015
48
0.500
Why?
Patient Discharge
1
2015
168
0.490
Why?
Length of Stay
1
2015
291
0.490
Why?
Drug Therapy, Combination
5
2018
273
0.480
Why?
Algorithms
1
2016
461
0.450
Why?
Health Status
5
2019
368
0.430
Why?
Adult
13
2019
8391
0.410
Why?
Randomized Controlled Trials as Topic
4
2019
462
0.400
Why?
Pleural Neoplasms
2
2007
11
0.390
Why?
Drug Administration Schedule
3
2019
246
0.390
Why?
Scavenger Receptors, Class A
2
2010
6
0.390
Why?
Respiratory Function Tests
4
2019
111
0.380
Why?
Codon, Nonsense
1
2010
5
0.370
Why?
Time Factors
5
2019
1997
0.370
Why?
Delayed-Action Preparations
3
2016
35
0.370
Why?
Age Factors
5
2018
1105
0.360
Why?
Promoter Regions, Genetic
2
2007
212
0.340
Why?
Dyspnea
3
2019
30
0.340
Why?
Aged, 80 and over
6
2019
3712
0.330
Why?
Respiratory Therapy
2
2018
4
0.330
Why?
Practice Guidelines as Topic
3
2018
373
0.310
Why?
Recovery of Function
2
2019
190
0.310
Why?
Peritoneal Neoplasms
2
2007
241
0.310
Why?
Interleukin-13
1
2007
33
0.310
Why?
Comorbidity
5
2016
539
0.300
Why?
Environmental Exposure
1
2007
86
0.300
Why?
Occupational Diseases
1
2006
83
0.270
Why?
Prostate-Specific Antigen
2
2003
61
0.270
Why?
Risk Factors
9
2019
3509
0.270
Why?
United States
7
2018
3604
0.260
Why?
Occupational Exposure
2
2006
224
0.260
Why?
Health Knowledge, Attitudes, Practice
2
2018
325
0.250
Why?
Logistic Models
6
2016
725
0.250
Why?
Sex Factors
5
2019
626
0.250
Why?
Asbestosis
1
2004
1
0.250
Why?
Prostatic Neoplasms
3
2003
441
0.230
Why?
Prevalence
7
2019
892
0.230
Why?
Inhalation
2
2019
8
0.210
Why?
Predictive Value of Tests
3
2016
784
0.210
Why?
Receptors, Androgen
1
2002
39
0.210
Why?
Regression Analysis
2
2017
272
0.210
Why?
Genetic Predisposition to Disease
4
2015
836
0.200
Why?
Polymorphism, Genetic
1
2002
196
0.200
Why?
Smoking Cessation
3
2015
118
0.200
Why?
Cohort Studies
3
2015
1674
0.190
Why?
Sensitivity and Specificity
3
2010
531
0.190
Why?
Patient Education as Topic
2
2018
251
0.180
Why?
Controlled Clinical Trials as Topic
1
2019
10
0.170
Why?
Prognosis
4
2015
1362
0.170
Why?
Clinical Trials, Phase III as Topic
1
2018
26
0.170
Why?
Retrospective Studies
2
2017
3107
0.170
Why?
North Carolina
3
2019
1422
0.170
Why?
Sleep
1
2019
84
0.170
Why?
Multivariate Analysis
2
2017
636
0.160
Why?
Preoperative Care
1
2019
110
0.160
Why?
Patient Care Team
1
2019
124
0.160
Why?
Body Mass Index
3
2016
862
0.160
Why?
Population Surveillance
2
2016
119
0.160
Why?
Inspiratory Capacity
1
2017
2
0.160
Why?
Disease Management
1
2018
114
0.160
Why?
Health Education
1
2018
121
0.160
Why?
Quality of Health Care
1
2018
134
0.150
Why?
Case-Control Studies
3
2010
855
0.150
Why?
Acute Disease
1
2017
239
0.150
Why?
Drug Delivery Systems
1
2017
92
0.150
Why?
Health Expenditures
1
2017
61
0.150
Why?
Patient Satisfaction
1
2018
222
0.140
Why?
Emergency Service, Hospital
1
2019
429
0.140
Why?
Forecasting
1
2016
133
0.130
Why?
Stereoisomerism
1
2015
21
0.130
Why?
Genotype
3
2007
735
0.130
Why?
Melanoma
1
2015
148
0.120
Why?
Reproducibility of Results
1
2016
724
0.120
Why?
Survival Rate
1
2016
795
0.120
Why?
Double-Blind Method
1
2014
501
0.110
Why?
Probability
2
2004
150
0.110
Why?
Adolescent
4
2016
3248
0.100
Why?
Risk Assessment
4
2015
1300
0.100
Why?
Behavioral Risk Factor Surveillance System
3
2016
9
0.100
Why?
Prospective Studies
3
2019
2010
0.100
Why?
Sex Distribution
2
2016
185
0.090
Why?
Macrophages
2
2010
188
0.090
Why?
Age Distribution
2
2016
197
0.090
Why?
Radiography, Thoracic
1
2010
43
0.090
Why?
Ethics, Professional
1
2009
6
0.090
Why?
Cell Adhesion
1
2010
103
0.090
Why?
Conflict of Interest
1
2009
39
0.090
Why?
Socioeconomic Factors
3
2016
385
0.090
Why?
ADAM Proteins
1
2009
13
0.090
Why?
Neoplasms
1
2015
608
0.090
Why?
Cell Survival
1
2010
272
0.090
Why?
Societies, Medical
1
2009
149
0.080
Why?
Phenotype
2
2009
629
0.080
Why?
Laundering
1
2007
4
0.080
Why?
Clothing
1
2007
5
0.080
Why?
Nuclear Family
1
2007
15
0.080
Why?
Air Pollution, Indoor
1
2007
7
0.080
Why?
Obesity
1
2015
1062
0.080
Why?
Cells, Cultured
1
2010
799
0.080
Why?
Linkage Disequilibrium
2
2009
192
0.080
Why?
Homozygote
1
2007
57
0.080
Why?
Heterozygote
1
2007
52
0.080
Why?
Neoplasms, Multiple Primary
1
2006
20
0.070
Why?
Family Health
1
2006
78
0.070
Why?
Health Surveys
2
2018
191
0.070
Why?
South Carolina
2
2016
29
0.070
Why?
Educational Status
1
2006
162
0.070
Why?
Polymerase Chain Reaction
2
2003
172
0.070
Why?
Analysis of Variance
2
2003
454
0.060
Why?
Young Adult
3
2016
2398
0.060
Why?
Biopsy, Needle
1
2004
89
0.060
Why?
Allelic Imbalance
1
2003
6
0.060
Why?
Administration, Oral
1
2004
169
0.060
Why?
Anti-Asthmatic Agents
1
2004
71
0.060
Why?
Receptors, Immunologic
1
2002
18
0.060
Why?
Immunohistochemistry
1
2004
519
0.050
Why?
Patient Compliance
1
2004
208
0.050
Why?
Dose-Response Relationship, Drug
1
2004
641
0.050
Why?
Base Sequence
1
2002
240
0.050
Why?
Molecular Sequence Data
1
2002
350
0.050
Why?
Cross-Sectional Studies
2
2016
1353
0.050
Why?
Linear Models
2
2015
425
0.050
Why?
Child
1
2007
2209
0.050
Why?
Genetic Variation
1
2002
251
0.050
Why?
Mutation
1
2002
466
0.050
Why?
Airway Resistance
1
2019
5
0.040
Why?
Sleep Apnea, Obstructive
1
2019
46
0.040
Why?
Tomography, X-Ray Computed
1
2004
871
0.040
Why?
Feasibility Studies
1
2019
262
0.040
Why?
Follow-Up Studies
1
2004
2106
0.040
Why?
Equipment Design
1
2017
167
0.040
Why?
Haplotypes
2
2009
220
0.040
Why?
Disease Susceptibility
1
2015
53
0.030
Why?
Cough
1
2015
19
0.030
Why?
Morbidity
1
2015
91
0.030
Why?
Risk Reduction Behavior
1
2015
115
0.030
Why?
Exercise Tolerance
1
2015
110
0.030
Why?
Self-Help Devices
1
2013
5
0.030
Why?
Health Behavior
1
2015
212
0.030
Why?
Arthritis
1
2013
37
0.030
Why?
Hospitalization
1
2016
417
0.030
Why?
Skin Neoplasms
1
2015
206
0.030
Why?
Genetic Markers
2
2003
122
0.030
Why?
Mental Health
1
2013
102
0.030
Why?
Activities of Daily Living
1
2013
237
0.030
Why?
Incidence
1
2015
1105
0.030
Why?
European Continental Ancestry Group
2
2009
1131
0.030
Why?
Exercise
1
2016
587
0.020
Why?
Diabetes Mellitus
1
2013
360
0.020
Why?
Constitution and Bylaws
1
2009
3
0.020
Why?
Organizational Policy
1
2009
20
0.020
Why?
Gene Frequency
1
2009
225
0.020
Why?
Stroke
1
2013
522
0.020
Why?
Hypertension
1
2013
899
0.020
Why?
Gene Amplification
1
2003
9
0.010
Why?
beta-Galactosidase
1
2003
16
0.010
Why?
Luciferases
1
2003
27
0.010
Why?
Cloning, Molecular
1
2003
74
0.010
Why?
Sequence Analysis, DNA
1
2003
138
0.010
Why?
Receptors, Scavenger
1
2002
7
0.010
Why?
Amino Acid Substitution
1
2002
40
0.010
Why?
Quality of Life
1
2008
815
0.010
Why?
DNA Mutational Analysis
1
2002
67
0.010
Why?
Protein Structure, Tertiary
1
2002
95
0.010
Why?
Pedigree
1
2002
133
0.010
Why?
African Continental Ancestry Group
1
2002
350
0.010
Why?
Ohar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (210)
Explore
_
Co-Authors (10)
Explore
_
Similar People (52)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_